Navigation Links
Omega Protein Reports 17 Cents Per Share Third Quarter Profit
Date:11/10/2008

HOUSTON, Nov. 10 /PRNewswire-FirstCall/ -- Omega Protein Corporation (NYSE: OME), the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $3.1 million (17 cents a share) for the third quarter of 2008, compared to net income of $7.2 million (42 cents a share) for the third quarter of the previous year.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO)

Revenues for the third quarter ended September 30, 2008 were $54.5 million compared with revenues of $44.6 million for the comparable quarter in 2007. Omega Protein recorded operating income of $5.3 million for the 2008 third quarter, versus operating income of $12.3 million for the third quarter of 2007.

For the nine months ended September 30, 2008, the Company had revenues of $137.7 million, compared with $112.8 million in revenues for the first nine months of 2007. Omega Protein recorded operating income of $21.0 million for the nine months ended September 30, 2008, versus operating income of $18.6 million for the comparable period a year earlier. The Company had net income of $11.7 million ($0.65 per share) for the nine months ended September 30, 2008, compared with net income of $7.4 million ($0.44 per share) for the nine months ended September 30, 2007.

As previously reported, during the quarter ended September 30, 2008, the Company suffered wind and flood damages to two of its facilities as a result of Hurricane Ike. The Company's Abbeville, Louisiana facility was restored to full capacity within a few weeks. The Company's Cameron, Louisiana facility is continuing its repairs and is expected to be fully functional for the beginning of the 2009 fishing season. The Company anticipates that its insurance policies will cover substantially all material property damage losses. The Company's third quarter results reflect decreased margins primarily due to significantly higher per unit production costs due to the lost fishing days caused by Hurricanes Gustav and Ike, combined with increased energy, labor and repair costs experienced during the 2008 fishing season. In addition, prior year third quarter results were favorably impacted by the settlement of the lawsuit with the Company's insurance carriers pertaining to damages sustained from Hurricanes Katrina and Rita in 2005.

The Company's 2008 nine month results, in comparison to the same nine months in 2007, after excluding the effects of hurricane losses, insurance recoveries and debt refinancing costs, experienced growth in revenues (22%), gross profit (34%) and net income (96%). The 2008 nine month results reflect increased pricing, particularly for fish oil, similar to other commodity markets during the first half of 2008. Commodity prices began to decrease in mid year and market uncertainty is high at this time. The global fish meal and fish oil markets tend to follow general commodity trends, albeit with less volatility. The Company believes it is well equipped to handle these changing markets due to its favorable financial position which includes a low debt to equity ratio and liquidity provided by internally generated cash, its bank credit facility and federal finance program loans.

About Omega Protein

Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward-looking statements include, among others: (1) the Company's estimates of damages or repair times being incorrect; (2) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control such as varying fish population, fish oil yields, adverse weather conditions and disease; (3) the impact of worldwide supply and demand relationships on prices for the Company's products; (4) Omega Protein's expectations regarding demand for OmegaPure(R) being incorrect; and (5) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its reports on Form 10- K, Form10-Q and Form 8-K. The Company also posts its latest internally generated price list for various products on its Company website, http://www.omegaproteininc.com. Pricing and product availability information disclosed in the price list are subject to change or discontinuance without prior notice, and the Company undertakes no obligation to update such information.

OMEGA PROTEIN CORPORATION

Statement of Operations

(unaudited)

Three Months Nine Months

Ended September 30, Ended September 30,

2008 2007 2008 2007

(in thousands, except per share amounts)

Revenues $54,507 $44,590 $137,774 $112,813

Cost of sales 43,923 33,640 102,976 86,805

Gross profit 10,584 10,950 34,768 26,008

Selling, general and

administrative expense 4,211 3,477 11,874 11,656

Research and development expense 630 278 1,280 665

(Insurance recoveries and other

proceeds) losses resulting from

natural disasters and other, net 423 (5,117) 608 (4,933)

Operating income 5,320 12,312 21,006 18,620

Interest income (expense), net (978) (1,204) (2,876) (4,010)

Loss resulting from debt refinancing - - - (3,024)

Other income (expense), net 107 (75) (17) (246)

Income before income taxes 4,449 11,033 18,113 11,340

Provision for income taxes 1,335 3,880 6,377 3,984

Net income $3,114 $7,153 $11,736 $7,356

Basic earnings per share $0.17 $0.42 $0.65 $0.44

Weighted average common shares

outstanding 18,624 16,971 18,160 16,635

Diluted earnings per share $0.16 $0.41 $0.63 $0.42

Weighted average common shares and

potential common share equivalents

outstanding 18,875 17,591 18,541 17,325

OMEGA PROTEIN CORPORATION

CONDENSED BALANCE SHEET

(Unaudited)

September 30, December 31,

2008 2007

(in thousands)

ASSETS

Current assets $140,266 $107,651

Property and equipment, net 102,554 96,659

Deferred tax assets, net - 175

Other assets 3,655 3,344

Total assets $246,475 $207,829

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities $43,945 $24,190

Long-term debt, less current maturities 53,195 58,976

Capital lease obligation, net of current portion 1,717 -

Pension liabilities, net and other 4,202 5,749

Interest rate swap liability, net of current

portion 189 459

Stockholders' equity 143,227 118,455

Total liabilities and stockholders' equity $246,475 $207,829

Book value per share outstanding $7.66 $6.79


'/>"/>
SOURCE Omega Protein Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Omega-3s Guard Against Type 1 Diabetes
2. Brain, Eye and Heart Health: Three Reasons to Eat More Omega-3s
3. Maine Natural Health Company Brings Omega-3 Benefits to Pets
4. Nordic Naturals Introduces Ultimate Omega 500 - Their Best Selling Formula Now Available in a Smaller Size Soft Gel!
5. Omega-3s Linked to Prevention of Parkinsons Disease and More
6. Nordic Naturals Professional Exclusive Division Redefines High Potency Omega-3 Supplementation With New Elite Line!
7. Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury
8. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
9. Omega Protein Reports 2007 Results
10. Infant formula must contain DHA omega-3 and AA omega-6, say international experts
11. Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... 23, 2016  The National Pharmaceutical Council (NPC) ... health policy research organization as its newest member.  ... senior vice president and chief scientific officer, Mallinckrodt ... the NPC Board of Directors. ... has joined us in support of our efforts ...
Breaking Medicine Technology: